用可吸入的洛瓦斯塔丁微球进行宿主导疗法,用于抑制结核病中的矩阵金属蛋白酶
Agrim Jhilta1, Krishna Jadhav1, Rahul Sharma2
1Institute of Nano Science and Technology (INST), Sector-81, Mohali, Punjab 140306, India.
ACS applied bio materials
|January 20, 2025
概括
在结核病模型中,可吸入的洛瓦斯塔丁微球有效降低了肺炎和组织损伤. 这种宿主导疗法显示出作为结核病 (TB) 辅助治疗的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 生物材料是一种生物材料.
背景情况:
- 结核病 (TB) 通过过度炎症和细胞外基质 (ECM) 降解引起肺组织破坏,由基质金属蛋白酶 (MMP) 介导.
- 主体导向疗法 (HDT) 旨在调节免疫反应以减轻结核病理.
- 洛瓦斯塔丁 (LOV) 具有抗炎性质,但具有不良的溶解性和生物相容性,限制了其治疗用途.
研究的目的:
- 为改善结核病治疗开发可吸入的含洛瓦斯塔丁的凝微球 (LOV/GA-MS).
- 评估LOV/GA-MS在抑制Mtb感染巨细胞的炎症和ECM损伤方面的疗效.
- 评估LOV/GA-MS与标准抗结核药物的协同作用潜力.
主要方法:
- 使用喷雾干燥技术制造了装有洛瓦斯塔丁 (LOV) 的可吸入凝微球 (GA-MS).
- 描述了LOV/GA-MS的粒子大小和空气动力学特性.
- 在体外研究中,使用感染Mycobacterium tuberculosis (Mtb) 的巨细胞进行了研究,以评估抗炎作用和药物协同作用.
主要成果:
- LOV/GA-MS显示了巨细胞吸收的最佳颗粒大小 (2.395 ± 0.67 μm).
- 在感染Mtb的巨细胞中,LOV/GA-MS显著抑制了MMP表达和促炎细胞因子.
- 当LOV/GA-MS与标准抗结核药物相结合时,观察到一种协同治疗效应in vitro.
结论:
- 吸入式LOV/GA-MS代表了结核病宿主导治疗的有希望的策略.
- 这种配方通过向MMP和减少炎症,有效调节免疫反应.
- LOV/GA-MS提供了一种潜在的方法来缓解肺组织损伤并提高结核病治疗结果.
更多相关视频
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
9.0K
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
2.3K
相关概念视频
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
01:28Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
01:19Antiasthma Drugs: Leukotriene Modifiers
241
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
241
01:26Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
01:29Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
01:23Inhaled Medications
236
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
236